|
 Compugen
and Roche
- Identify genetic variations predictive of drug
response in rheumatoid arthritis patients
- Press release 12.20.07
Idera
and Merck
Medicis
and Revance Therapeutics
- Purchase an option to acquire Revance or to
license topical botulinum toxin type A
- Press release 12.11.07
GE
Healthcare and Novavax
- Develop and market pandemic influenza solution
- Press release 12.10.07
Immtech
and BioAlliance Pharma SA
Regeneron
and Sanofi-aventis
Crucell
and Acambis
- PER.C6 (R) for an undisclosed vaccine candidate
-
Form 6-F 11.21.07
Inhibitex
and Cardiff University
Amicus
Therapeutics and Shire plc
CombinatoRx
and Dart Therapeutics
- Research focused on identifying clinical
combination drug candidates as potential treatments for Duchenne's
Muscular
Dystrophy
- Press release 11.08.07
XenoPort
and Xanodyne Pharmaceuticals
Ariad
and ICON Medical
- Drug-eluting stents that deliver mTOR inhibitor
- Press release
10.11.07
Genaera
Corporation and MacroChem
- Licensing of exclusive rights to Pexiganan
-
Press release
10.03.07
OSI
Pharmaceuticals and AVEO Pharmaceuticals
Array
BioPharma and Celgene
Isis
and Ortho-McNeil
Isis
and Alnylam
Baxter
and Halozyme
- Commercialize product combinations of rHuPH20
SGX
and BCR-ABL
- Commercialization of BCR-ABL inhibitors
Icagen
and Pfizer
- Development of ion channel and modulators
Dyax
and Cambridge Antibody Technology Limited
Alnylam
and Medtronic
- Discovering and developing siRNA-based
therapeutics
- Form 8-K 7.27.07
Penwest
and Edison
- Collaborating on activities relating to A0001
Ariad
and Merck
- Related to mTOR inhibitor compounds
Tercica
and Genentech
- Worldwide growth hormone and IGF-1 combination
Novavax
and Wyeth
- Rights to a patent application covering
virus-like particle
Alnylam
and Roche
- Commercialize therapeutic products that function
through RNA interference
ZymoGenetics
and Bayer HealthCare
- Recombinant human
thrombin
Combinatorx
and Fovea
- Certain ophthalmic indications of
combination drug candidates
Bristol-Myers
and ISIS
Micromet and Nycomed
Genetech
and Sangamo
BioCryst
and Shionogi
Genvec
and Department of Homeland Security
Sequenom
and Lenetix
Seattle
Genetics and Agensys
Seattle
Genetics and Genentech
|
Covers
collaborations and licensing deals 
